Under30CEO on MSN
SAFEs vs convertible note: Which is right for a pre-seed round
You finally have investor interest. A couple of angels like the idea, one says “We usually do SAFEs,” another asks if you’re ...
Under30CEO on MSN
What is a convertible note (and when founders should use one)
You’re a few months into building. You have early users, a half-working product, and one investor asking for your “valuation expectations.” You have no idea what to say. A friend tells you to “just ...
The Details: IREN announced a private offering of ordinary shares in order to fund the repurchase of its existing 2029 convertible notes and existing 2030 convertible notes. IREN also announced its ...
MINNEAPOLIS, July 28, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) (the “Company”), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today ...
WATSONVILLE, Calif.--(BUSINESS WIRE)--Granite Construction Incorporated (NYSE: GVA) (“Granite”) today announced the pricing of its previously announced offering of $325 million aggregate principal ...
NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) (“IREN”) today announced its intention to commence a registered direct offering of ordinary shares (the “Offering”) to a limited ...
NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) -- IREN Limited (IREN) (“IREN”) today announced its intention to offer, subject to market and other conditions, $1 billion aggregate principal amount of ...
MIDLAND, Texas--(BUSINESS WIRE)--AST SpaceMobile, Inc. (“AST SpaceMobile”) (NASDAQ: ASTS), the company building the first and only space-based cellular broadband network accessible directly by ...
The Company has granted the initial purchasers of the Convertible Notes an option to purchase, for settlement within a 7-day period beginning on, and including the date on which the Convertible Notes ...
97% of Beyond Meat's convertible notes due March 2027 were tendered by the early tender deadline. It is reducing its net debt by over $800 million, but still faces major challenges with cash burn. I ...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that it has entered into separate, privately negotiated exchange agreements with a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results